Recombinant Progranulin (New York University Medical Center)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Progranulin (New York University Medical Center)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGlucosylceramidase modulators
TargetsGlucosylceramidase
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNyu Langone Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNyu Langone Health
Active IndicationsN/A
Inactive IndicationsGaucher Disease

Other Information

ATC CodeN/A
Related LinksN/A